China Pharma Holdings (CPHI) Other Operating Expenses (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Other Operating Expenses came in at $92717.0 in Q1 2026, up 8.08% YoY from $85788.0 in Q1 2025, and up 12.64% on a QoQ basis from $82313.0 in Q4 2025.
China Pharma Holdings (CPHI) Other Operating Expenses (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Other Operating Expenses data on file, last reported at $92717.0 in Q1 2026.
- Quarterly Other Operating Expenses rose 8.08% year-over-year to $92717.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $381697.0 (down 25.77% YoY) and the FY2025 annual result came in at $374768.0, down 29.89% from the prior year.
- Other Operating Expenses grew to $92717.0 in Q1 2026, from $82313.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $354261.0 in Q4 2022 to a low of $82313.0 in Q4 2025.
- A 5-year average of $161324.5 and a median of $134396.0 in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 30.05% — and 2025, when it plunged 53.11%.
- Tracing CPHI's Other Operating Expenses over 5 years: stood at $354261.0 in 2022, then fell by 24.35% to $267996.0 in 2023, then slumped by 34.5% to $175527.0 in 2024, then plunged by 53.11% to $82313.0 in 2025, then increased by 12.64% to $92717.0 in 2026.
- The last three Other Operating Expenses figures came in at $92717.0 (Q1 2026), $82313.0 (Q4 2025), and $103343.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,717.00 |
| Dec 31, 2025 | 82,313.00 |
| Sep 30, 2025 | 103,343.00 |
| Jun 30, 2025 | 103,324.00 |
| Mar 31, 2025 | 85,788.00 |
| Dec 31, 2024 | 175,527.00 |
| Sep 30, 2024 | 132,947.00 |
| Jun 30, 2024 | 119,931.00 |
| Mar 31, 2024 | 106,121.00 |
| Dec 31, 2023 | 267,996.00 |
| Sep 30, 2023 | 188,312.00 |
| Jun 30, 2023 | 173,867.00 |
| Mar 31, 2023 | 134,396.00 |
| Dec 31, 2022 | 354,261.00 |
| Sep 30, 2022 | 185,540.00 |
| Jun 30, 2022 | 262,093.00 |
| Mar 31, 2022 | 174,040.00 |
| Dec 31, 2021 | 286,280.00 |
| Sep 30, 2021 | 142,664.00 |
| Jun 30, 2021 | 440,734.00 |